A099430 Stock Overview
Engages in the research and development, production, and sale of bio products in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Bio Plus Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,885.00 |
| 52 Week High | ₩7,450.00 |
| 52 Week Low | ₩4,250.00 |
| Beta | 0.65 |
| 11 Month Change | -15.92% |
| 3 Month Change | -19.39% |
| 1 Year Change | -26.43% |
| 33 Year Change | -10.78% |
| 5 Year Change | n/a |
| Change since IPO | -39.78% |
Recent News & Updates
Earnings Not Telling The Story For Bio Plus Co., Ltd (KOSDAQ:099430) After Shares Rise 29%
Jul 23
The Returns On Capital At Bio Plus (KOSDAQ:099430) Don't Inspire Confidence
Jul 05Recent updates
Earnings Not Telling The Story For Bio Plus Co., Ltd (KOSDAQ:099430) After Shares Rise 29%
Jul 23The Returns On Capital At Bio Plus (KOSDAQ:099430) Don't Inspire Confidence
Jul 05More Unpleasant Surprises Could Be In Store For Bio Plus Co., Ltd's (KOSDAQ:099430) Shares After Tumbling 31%
Jun 08Additional Considerations Required While Assessing Bio Plus' (KOSDAQ:099430) Strong Earnings
Mar 26Shareholder Returns
| A099430 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -7.3% | 6.1% | -2.8% |
| 1Y | -26.4% | 14.9% | -3.4% |
Return vs Industry: A099430 underperformed the KR Medical Equipment industry which returned 14.9% over the past year.
Return vs Market: A099430 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A099430 volatility | |
|---|---|
| A099430 Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A099430 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A099430's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 86 | Hyun-Kyu Jung | www.ubioplus.co.kr |
Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms.
Bio Plus Co., Ltd Fundamentals Summary
| A099430 fundamental statistics | |
|---|---|
| Market cap | ₩278.12b |
| Earnings (TTM) | ₩20.01b |
| Revenue (TTM) | ₩54.58b |
13.9x
P/E Ratio5.1x
P/S RatioIs A099430 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A099430 income statement (TTM) | |
|---|---|
| Revenue | ₩54.58b |
| Cost of Revenue | ₩22.43b |
| Gross Profit | ₩32.15b |
| Other Expenses | ₩12.13b |
| Earnings | ₩20.01b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 351.51 |
| Gross Margin | 58.90% |
| Net Profit Margin | 36.67% |
| Debt/Equity Ratio | 3.0% |
How did A099430 perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield20%
Payout RatioDoes A099430 pay a reliable dividends?
See A099430 dividend history and benchmarks| Bio Plus dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 09 2025 |
| Days until Ex dividend | 37 days |
| Days until Dividend pay date | 140 days |
Does A099430 pay a reliable dividends?
See A099430 dividend history and benchmarks